Summary of Findings
Research Reports
Research Meetings
How to Apply
Research Resources
Line
Research
 

FRAXA funds research leading to treatments and a cure for Fragile X.

In 1991, Ben Oostra, Stephen Warren, and David
Nelson discovered the gene for Fragile X, FMR1.
FRAXA is the name they gave the mutation
on FMR1 which causes Fragile X
  • Summary of Findings: What do we know and how close are we to delivering treatments and a cure?

  • Research Reports: All FRAXA grants, by year, are described here. Each FRAXA investigator has a page about his/her project.

  • Applying for FRAXA Grants: FRAXA's research priorities, application information, renewal and final report guidelines.

  • Research Program:
    Neurobiology of Fragile X and Autism    : Nine partners, including NIH & FRAXA, are sponsoring this joint funding program. Expires 7/2/08.

  • Research Resources: For researchers; sources for reagents including experimental compounds, antibodies, mice, and tissue.

  • Research Meetings: FRAXA organizes and supports research meetings to spur on progress.

    • Join Researcher's Mailing List
     
     
    Name:   Organization:
    Email:        Preferred Email Type: HTML Text
    Subscribe  Unsubscribe 
©1997-2008 FRAXA Research Foundation, 45 Pleasant St., Newburyport, MA 01950. Phone: 978-462-1866. Contact Us
Editor/writers: Katie Clapp, MS, and Michael Tranfaglia, MD. Updated 4/11/08. All rights reserved. Disclaimer Created by Hookumu